Experience With New Chemotherapeutic Agents in Non-small Cell Lung Cancer

This publication has 18 references indexed in Scilit:

• Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.
  Journal of Clinical Oncology, 1994
• Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results
  JNCI Journal of the National Cancer Institute, 1993
• Chemotherapy of Lung Cancer
  New England Journal of Medicine, 1992
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma
  JNCI Journal of the National Cancer Institute, 1992
• Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1991
• A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer
  American Journal of Clinical Oncology, 1991
• A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1990
• Taxol: A Novel Investigational Antimicrotubule Agent
  JNCI Journal of the National Cancer Institute, 1990
• Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2'-difluoro-D-ribofuranosyl nucleosides
  The Journal of Organic Chemistry, 1988